Tagged with EpimAb

China: EpimAb Looks to 2022 IPO & Global Leadership in Bispecific Antibodies
China Pharma News: Antitrust Threat to Pharma; June BioNTech Vaccine Approval; EpimAb IPO; CanSino Inhaled Vaccine Trials
5 More Biotechs to Watch in China
Chengbin Wu – CEO, EpimAb Biotherapeutics, China
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here